Medroxyprogesterone Acetate Injection
Lack of Assurance of Sterility
84 recalls, newest first
Lack of Assurance of Sterility
MICROBIAL CONTAMINATION OF NON-STERILE PRODUCT: microbial contaminant identified as Pluralibacter gergoviae.
Superpotent Drug: Minimally superpotent
Superpotent Drug
Defective container: Out of specification for container integrity leading to bottles leaking.
Labeling; Label mix-up and Wrong Bar Code; back label incorrectly states active ingredient as Menthol with UPC 7 14132 00071 4 instead of Peppermint Oil and Sage Oil with UPC 7 14132 00073 8
Labeling: Not Elsewhere Classified: the controlled substance classification "CIII" is missing on the label
Labeling: Not Elsewhere Classified: the controlled substance classification "CIII" is missing on the label
Labeling: Incorrect Instructions
CGMP Deviations: Presence of the N-nitroso-varenicline impurity above FDA s acceptable interim acceptable intake limit
CGMP Deviations: Presence of the N-nitroso-varenicline impurity above FDA s acceptable interim acceptable intake limit
CGMP Deviations: Presence of the N-nitroso-varenicline impurity above FDA s acceptable interim acceptable intake limit
CGMP Deviations: Presence of the N-nitroso-varenicline impurity above FDA s acceptable interim acceptable intake limit
Superpotent Drug
Failed Stability Specifications; out of specification for shear.
Failed Stability Specifications; out of specification for shear.
Defective container: possibility for lack of seal integrity.
Marketed without ANDA/NDA approval
Marketed Without an Approved NDA/ANDA: FDA analysis determined the presence of tadalafil
cGMP Deviations
Chemical Contamination: presence of benzene